4.6 Article

REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells

Journal

CELL CYCLE
Volume 8, Issue 5, Pages 780-786

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.8.5.7887

Keywords

REDD1; RAS; ovarian cancer; transformation; anti-apoptosis

Categories

Funding

  1. American Cancer Society [RSG-04-0281-CCE]
  2. National Institutes of Health/National Cancer Institute (NIH/NCI) [R01 CA131183-01]
  3. NATIONAL CANCER INSTITUTE [P30CA016672, R01CA131183] Funding Source: NIH RePORTER

Ask authors/readers for more resources

REDD1 is a gene induced by hypoxia and stimuli from multiple DNA damage. Here we show that REDD1 expression was elevated in RAS-transformed ovarian epithelial cells lines and that this overexpression increased these cells' growth rate and anchorage-independent growth on soft agar. Injection of immortalized ovarian epithelial cells overexpressing REDD1 into nude mice resulted in tumor growth that developed into papillary serous carcinoma in the peritoneal cavity. Knockdown of REDD1 expression blocked the RAS-mediated transformation of these cell lines. REDD1 overexpression decreased apoptosis and associated with increased expression of Bcl-xL or Bcl-2 and decreased expression of FADD, caspase1, caspase8, caspase 9, caspase 10, BAX, Bad and Bcl-XS. Our data demonstrated that REDD1 is a key mediator in RAS-mediated transformation through an effect on anti-apoptosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available